Delivery Order SPE2DB22D2214-SPE2DB25FS6LR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,604.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $2,152.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This non-set-aside competitive award is scheduled for completion by September 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,047.66 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,010.60 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,461.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone injection medication. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,774.76 for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. The contract was competitively awarded without set-aside designation on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,629.67 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL injectable medication. The contract, which carries no set-aside designation, is scheduled for completion by September 2, 2025, with performance taking place at the vendor's Conshohocken facility. This delivery...
- AmerisourceBergen Drug Corp was awarded a $2,822.39 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 ml. The award is non-set-aside and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. Performance will be completed by September 4, 2025, with services executed at the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,259.34 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6LRDelivery Order
The Defense Logistics Agency awarded a $2,993.44 delivery order to AmerisourceBergen Drug Corp for NORDITROPIN FLEXPRO 15 MG/1.5 ML, a human growth hormone medication. This firm fixed-price contract was competitively awarded without set-aside restrictions and is scheduled for completion by September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. This award is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.999 billion through December 2026. This prime vendor contract serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal pharmaceutical portfolio demonstrates its role as a critical supplier for military medical procurement, with consistent delivery order awards across diverse therapeutic categories including specialty medications, vaccines, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/5/25 |